These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The detection of heterozygous familial hypercholesterolemia in Ireland. O'Kane MJ, Menown IB, Graham I, Maher V, Tomkin G, Nicholls P, Graham C. Adv Ther; 2012 May; 29(5):456-63. PubMed ID: 22610724 [Abstract] [Full Text] [Related]
4. Algorithm for detection and screening of familial hypercholesterolemia in Lithuanian population. Aliosaitiene U, Petrulioniene Z, Rinkuniene E, Mainelis A, Brazdziuniene E, Smailyte U, Sileikiene V, Laucevicius A. Lipids Health Dis; 2024 May 07; 23(1):136. PubMed ID: 38715054 [Abstract] [Full Text] [Related]
7. Reverse Cascade Screening for Familial Hypercholesterolemia. Vinson A, Guerra L, Hamilton L, Wilson DP, Fnla. J Pediatr Nurs; 2019 May 07; 44():50-55. PubMed ID: 30683281 [Abstract] [Full Text] [Related]
9. Cascade screening and genetic diagnosis of familial hypercholesterolemia in clusters of the Southeastern region from Brazil. de Paiva Silvino JP, Jannes CE, Tada MT, Lima IR, Silva IFO, Pereira AC, Gomes KB. Mol Biol Rep; 2020 Dec 07; 47(12):9279-9288. PubMed ID: 33231818 [Abstract] [Full Text] [Related]
10. Cascade screening for familial hypercholesterolemia: Practical consequences. Louter L, Defesche J, Roeters van Lennep J. Atheroscler Suppl; 2017 Nov 07; 30():77-85. PubMed ID: 29096865 [Abstract] [Full Text] [Related]
11. Asymptomatic Intracranial Artery Stenosis/Occlusion in Heterozygous Familial Hypercholesterolemia: Its Frequency and Implications for Cerebrovascular and Cardiovascular Events. Funabashi S, Kataoka Y, Hori M, Ogura M, Doi T, Morita Y, Kiyoshige E, Nishimura K, Noguchi T, Harada-Shiba M. J Am Heart Assoc; 2024 Aug 06; 13(15):e033972. PubMed ID: 39011964 [Abstract] [Full Text] [Related]
13. Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia. Reijman MD, Defesche JC, Wiegman A. Curr Opin Lipidol; 2023 Dec 01; 34(6):287-295. PubMed ID: 36752612 [Abstract] [Full Text] [Related]
14. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia. Wald DS, Wald NJ. J Med Screen; 2019 Jun 01; 26(2):71-75. PubMed ID: 30319009 [Abstract] [Full Text] [Related]
15. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk. Lee S, Akioyamen LE, Aljenedil S, Rivière JB, Ruel I, Genest J. Eur J Prev Cardiol; 2019 Aug 01; 26(12):1262-1270. PubMed ID: 30755017 [Abstract] [Full Text] [Related]
16. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil. Silva PRS, Jannes CE, Oliveira TGM, Miname MH, Rocha VZ, Chacra AP, Gurgel MHC, Montenegro RM, Rodrigues Sobrinho CRM, Bello Moreira AS, Assad MHV, Pinto MRC, Tada MT, Santos RD, Pereira AC, Krieger JE. Atherosclerosis; 2017 Aug 01; 263():257-262. PubMed ID: 28689098 [Abstract] [Full Text] [Related]
20. Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods. Ibrahim S, Reeskamp LF, Stroes ESG, Watts GF. Curr Opin Lipidol; 2020 Dec 01; 31(6):347-355. PubMed ID: 33027222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]